Clinical Trials

We are conducting early safety and efficacy trials for vaccines, as well as treatment options and observational studies in the field of infectiology.

Ongoing Trials

• MVA-MERS-S-Phase 1b Vaccine Trial (NCT04119440)
• TherVacB Phase 1a Trial (NCT05727267)
• mEX-TB study – Cohort study

• COVID-19 Studies at the UKE
• Nationales Pandemie Kohorten Netz des Netzwerk Universitätsmedizin

In cooperation with the Bernhardt Nocht Center for Clinical Trails ( BNCCT )

• CMVictory Phase 3 Trial (NCT05085366)

More information on UKE - Institute for Infection Research and Vaccine Development (IIRVD)